Online inquiry

IVTScrip™ mRNA-Human AGTRAP, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A))   (CAT#: GTTS-WK15918MR)

This product GTTS-WK15918MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 0 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the AGTRAP protein. This product can be used in Oogenesis phase fetal germ cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 0
Species Human
RefSeq NM_001040194.2
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 57085
UniProt ID Q6RW13
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human AGTRAP, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) (GTTS-WK15918MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK5343MR IVTScrip™ mRNA-Human CD133, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA CD133
GTTS-WK10708MR IVTScrip™ mRNA-Human ADAMTSL1, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ADAMTSL1
GTTS-WK24044MR IVTScrip™ mRNA-Human APPL2, (Cap 0, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA APPL2
GTTS-WK20334MR IVTScrip™ mRNA-Human ANKRD65, (Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ANKRD65
GTTS-WK17930MR IVTScrip™ mRNA-Human ANKRD50, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ANKRD50
GTTS-WK21501MR IVTScrip™ mRNA-Human ANKRD13D, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ANKRD13D
GTTS-WK20321MR IVTScrip™ mRNA-Human ANKRD36BP1, (Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ANKRD36BP1
GTTS-WK28021MR IVTScrip™ mRNA-Human ARHGEF6, (Cap 1, 2-Thio-UTP, 30 nt-poly(A)) mRNA ARHGEF6
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
webinar

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST

REGISTER NOW